Business Wire

AMGTA Announces EOS as New Principal Member and Appoints Björn Hannappel to Board of Directors

22.1.2026 13:59:00 CET | Business Wire | Press Release

Share

The Additive Manufacturer Green Trade Association (AMGTA) today announced that EOS has elevated its longstanding participation in the association to Principal Member. As part of this expanded leadership role, Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260121601881/en/

Björn Hannappel, Head of Sustainability at EOS, has joined the AMGTA Board of Directors.

Principal Membership represents AMGTA’s highest level of engagement and is reserved for organizations demonstrating sustained leadership, strategic alignment, and a commitment to advancing sustainable and resilient manufacturing practices globally. As a Principal Member, EOS will take on an expanded role in shaping AMGTA’s strategic direction, governance, and industry collaboration initiatives.

EOS is a world-leading technology supplier in the field of commercial 3D printing of metals and polymers. Formed in 1989, the independent company is a pioneer and innovator in comprehensive additive manufacturing solutions. Its portfolio of EOS systems, materials, and process parameters provides customers with critical competitive advantages in product quality and the long-term economic sustainability of their manufacturing processes. Customers also benefit from EOS’s deep technical expertise across global service, applications engineering, and consultancy.

“I am thrilled to welcome EOS and Björn Hannappel to this expanded role in shaping AMGTA,” said Sherri Monroe, AMGTA Executive Director. “EOS’s elevation to Principal Member reflects both the company’s established leadership in additive manufacturing and its commitment to advancing sustainability at scale. We are also pleased to welcome Björn Hannappel to the AMGTA Board, where his expertise will strengthen our ability to deliver meaningful, industry-driven outcomes.”

“EOS exemplifies the kind of leadership the AMGTA seeks to elevate—combining technological innovation with a disciplined, outcomes-driven approach to sustainability,” said Brian Neff, AMGTA Board Chair and CEO of Sintavia. “Björn Hannappel’s appointment to the Board strengthens our collective ability to guide the additive manufacturing ecosystem toward solutions that are not only more efficient and resilient, but also economically and environmentally sound.”

As Head of Sustainability at EOS, Hannappel leads initiatives focused on environmental performance, resource efficiency, and long-term value creation across industrial additive manufacturing systems. In his role on the AMGTA Board of Directors, he will contribute to guiding the organization’s mission, priorities, and global impact.

“The decision to deepen our engagement with AMGTA aligns closely with EOS’s commitment to responsible innovation and sustainable industrial transformation,” said Hannappel. “Additive manufacturing is already reshaping how products are designed, produced, and delivered, and collaboration across the ecosystem is essential to realizing its full environmental and economic potential.”

The AMGTA is the only independent, global organization bringing together companies across the manufacturing ecosystem to elevate and advance the conversation around 3D printing and additive manufacturing practices for improved environmental, economic, and resource-efficient outcomes. In an increasingly volatile and uncertain business climate, commercial 3D printing and additive practices are being adopted as critical technologies—supporting everything from new product design to reducing standing inventory costs and obsolescence.

Additive manufacturing technologies are now present across a wide range of applications, from medical implants and consumer electronics to aerospace, industrial products, and defense. Collectively referred to as additive manufacturing, or AM, these technologies are enabling businesses to be more responsive, innovative, economically viable, and sustainable. Today—and increasingly in the future—the unique capabilities enabled by 3D printing and additive practices are fundamentally changing how organizations compete and succeed in a rapidly evolving global economy.

Björn Hannappel’s appointment is effective January 1, 2026.

About the Additive Manufacturer Green Trade Association (AMGTA)

The AMGTA is a global trade association dedicated to advancing sustainable, resilient, and economically viable manufacturing through commercial 3D printing and additive technologies. Through collaboration, data-driven insights, and industry leadership, AMGTA supports manufacturers, suppliers, and stakeholders worldwide in accelerating responsible adoption of additive manufacturing.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260121601881/en/

Contacts

Media Contact:
Sherri Monroe
Executive Director
SMonroe@AMGTA.org
+1 386-216-7396

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release

inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye